The PROCLIPI international registry of early‐stage mycosis fungoides identifies substantial diagnostic delay in most patients
British Journal of Dermatology2018Vol. 181(2), pp. 350–357
Citations Over TimeTop 1% of 2018 papers
Julia Scarisbrick, Pietro Quaglino, H. Miles Prince, Evangelia Papadavid, Emmilia Hodak, M. Bagot, Octavio Servitje, Emilio Berti, Pablo L. Ortiz‐Romero, Rudolf Stadler, Aikaterini Patsatsi, Robert Knobler, Emmanuella Guenova, Fiona Child, Sean Whittaker, Vasiliki Nikolaou, Carlo Tomasini, Iris Amitay, Hadas Prag Naveh, C. Ram‐Wolff, Maxime Battistella, Silvia Alberti Violetti, René Stranzenbach, Vanessa Gargallo, Cristina Muniesa, Triantafyllia Κoletsa, Constanze Jonak, Stefanie Porkert, Christina Mitteldorf, Teresa Estrach, Andrea Combalía, Márta Marschalkó, Judit Csomor, Ágota Szepesi, Antonio Cozzio, Reinhard Dummer, Nicola Pimpinelli, Vieri Grandi, M. Beylot‐Barry, Anne Pham‐Ledard, Marion Wobser, Eva Geissinger, Ulrike Wehkamp, Michael Weichenthal, Richard Cowan, Eileen Parry, Jeremy P. Harris, Rachel Wachsmuth, Deborah Turner, Andrew Bates, Eugene Healy, Franz Trautinger, Johanna Latzka, Jungmin Yoo, B. Vydianath, Rasoul Amel-Kashipaz, Leonidas Marinos, A. Oikonomidi, Alexander Stratigos, Marie‐Dominique Vignon‐Pennamen, Maxime Battistella, Fina Climent, Eva González‐Barca, Elisavet Georgiou, Rebecca Senetta, Pier Luigi Zinzani, Liisa Väkevä, Annamari Ranki, A.M. Busschots, Esther Hauben, An Bervoets, Feng Jung Sherida H. Woei-A-Jin, Rubeta Matin, Graham P. Collins, Sophie Weatherhead, J. Frew, Mike Bayne, Giles Dunnill, Pam McKay, Arvind Arumainathan, Richard Azurdia, Kim Benstead, Robert Twigger, Kerri E. Rieger, Ryanne A. Brown, José Antônio Sanches, Denis Miyashiro, Oleg E. Akilov, Sue McCann, Helka Sahi, Fabiana Damasco, Christiane Querfeld, Amy Folkes, Cecilia Bur, C.‐D. Klemke, Paula Enz, Ramón M. Pujol, Koen D. Quint, Larisa J. Geskin, Eric Hong, Felicity Evison, Maarten H. Vermeer, Lorenzo Cerroni, Werner Kempf, Youn H. Kim, Rein Willemze
Abstract
This confirmed early-stage MF cohort is being followed-up to identify prognostic factors, which may allow better management and improve survival by identifying patients at risk of disease progression. This study design is a useful model for collaboration in other rare diseases, especially where pathological diagnosis can be complex.
Related Papers
- → ADVANCES IN THE MANAGEMENT OF CUTANEOUS T-CELL LYMPHOMA(1998)16 cited
- → Cutaneous T-cell lymphoma (mycosis fungoides)(1996)9 cited
- → Efficacy of chlormethine gel in patients with stage I–IIA mycosis fungoides cutaneous T-cell lymphoma (MF-CTCL): re-analysis of a randomized phase 2 study(2019)
- → Efficacy and quality of life (QoL) in patients with mycosis fungoides cutaneous T-cell lymphoma (MF-CTCL) treated with chlormethine gel and other therapies: results from the PROVe study(2019)
- → 43705 Non-invasive molecular analysis for CTCL detection and differentiation from other skin conditions(2023)